Rutgers Researchers Call for Balanced Approach to E-Cigarette Use

Jul.25.2022
Rutgers experts urge balanced approach to examining latest trends in adult e-cigarette use, citing potential benefits and health concerns.

Researchers from Rutgers University are urging for a balanced approach to reviewing the latest trends in adult electronic cigarette use.


Assistant Professor Julia Chen-Sankey and Lecturer Michelle T of the Department of Health Behavior, Society, and Policy at Rutgers School of Public Health, along with Lecturer Bover-Manderski of the Department of Biostatistics and Epidemiology at Rutgers, suggest that while there are clear health concerns associated with using e-cigarettes, particularly among those who have not previously used tobacco products, there are also potential benefits that should not be overlooked.


Researchers at Rutgers University have published an invited commentary in the Journal of the American Medical Association (JAMA) Network Open, reviewing new data on the trend of electronic cigarette use among American adults. The researchers, Chen-Sankey and Bover-Manderski, are also members of the Rutgers Tobacco Studies Center. They discuss the necessity of public health approaches to achieve a balance between risks and potential of electronic cigarettes in promoting smoking cessation among adults who currently use combustible cigarettes.


This study raises important questions about the use of electronic cigarettes by adults in the United States. What did the study find and what questions does it pose for public health policy?


Chen-Sankey's research paper explores the latest trends in electronic cigarette use among adults in the United States in 2017, 2018, and 2020. One of the key findings is that while the use of e-cigarettes among young adults aged 18 to 20 has decreased from 2018 to 2020, it has increased among other age groups. Additionally, there has been an increase in the frequency of daily e-cigarette use among current users.


Perhaps the most shocking revelation is that the usage of e-cigarettes among those who have never smoked combustible cigarettes has significantly increased. While e-cigarettes may have the potential to aid in smoking cessation, there has also been a decrease in the number of traditional smokers attempting to quit.


Bover-Manderski: How can these contradictory findings be applied to health policies? It is important to strike a balance between new teenage users and older smokers who want to quit.


Question: How do we strike this balance?


Chen-Sankey suggests that certain policy developments and strategies could ensure the public health benefits of using e-cigarettes. For instance, the recent authorization of e-cigarette products in the United States. The Food and Drug Administration (FDA) through its PMTA review could help establish public trust in authorized e-cigarette products.


Bover-Manderski stated that in order to increase the acceptance of traditional smokers using e-cigarettes as a means to quit smoking, public health education and mass media dissemination strategies should focus on promoting the evidence-based results of e-cigarettes harm reduction.


Question: Why do some traditional adult smokers refuse to use e-cigarettes as a method to quit smoking?


Chen-Sankey stated that in the past five years, the appeal of e-cigarette products for traditional smokers interested in quitting has decreased, but they have become more attractive to non-smokers. Several factors can help explain this frustrating pattern.


Firstly, policies aimed at reducing youth use of electronic cigarettes may also decrease interest and use among adult smokers attempting to quit. Additionally, media coverage may be shaping smokers' understanding of e-cigarettes as the amount of reporting on the risks for youth using e-cigarettes outweighs the potential benefits for adult combustible cigarette users.


Bover-Manderski suggests that public health organizations and healthcare professionals may need to shift their focus from the potential benefits of using combustible tobacco products among adults, to the risks associated with young people using e-cigarettes.


Question: One highlight of this study was a significant decrease in the proportion of young people aged 18 to 20 who use e-cigarettes. What explains this decrease?


Chen-Sankey suggests that this discrepancy may be related to the Tobacco Act, which limits the sale of tobacco and nicotine products, including e-cigarettes, to this age group starting in January 2020. Another potential explanation is the national restrictions implemented in February 2020 on certain flavored e-cigarettes, which may have significantly reduced their appeal among young people.


Bover-Manderski stated that it is important to acknowledge the impact of COVID-19-related lockdowns and social distancing requirements, which may restrict opportunities for this demographic to use e-cigarettes in social or group settings.


I'm sorry, but I do not have context or any text to translate to standard journalistic English. Please provide more information.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
According to Interfax-Ukraine, a study conducted by market research firm Kantar Ukraine at the request of major tobacco companies found that more than 93% of vape products in Ukraine did not fully comply with regulatory requirements. The research examined product categories, brand distribution and consumer purchasing channels, showing that pod systems and disposable vapes represent major segments of the market, while offline retail remains the dominant purchasing channel. The findings highlight ongoing compliance challenges in Ukraine’s vape market.
Aug.26
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24